Cephalexin Completed Phase 4 Trials for Mild to Moderate Uncomplicated Skin and Skin Structure Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00234949A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections